Strait Access Technologies (SAT) was founded in 2008 as a start-up company of the University of Cape Town. Its objective was the development of trans-catheter technologies that would provide access to heart valve therapies for the millions of patients suffering from Rheumatic Heart Disease (RHD) in Emerging Economies and the Developing World. By addressing the needs of these patients through simplicity superior spin-off products also emerged for the established procedures of the industrialised world.
SAT was founded by a small team of clinical and biomedical professionals operating at the interface of the Industrialised and the Developing World. The founders have applied their extensive experience and expertise in cardiac surgery and medical devices to the goal of making life-saving implantable devices accessible to the millions of patients with rheumatic heart disease (RHD) who are excluded from currently available therapies.
- OpenCEO and Medical Director
- OpenTechnical Director
- OpenChairman of the Board